Pancreatic cancer biomarker. Dan G. Duda


Chirurgia Bucur ; 5 :Sept-Oct.

pancreatic cancer biomarker hpv cervical cancer developing countries

pancreatic cancer biomarker Sarcopenia represents a decrease in the skeletal muscle mass and function and is usually associated with the aging process. The prevalence of sarcopenia in patients with gastric cancer is reported to be as high as Although many studies support the negative impact of sarcopenia in patients with gastric cancer, contradictory results are also present in the literature.

pancreatic cancer biomarker

The objective of this study is to investigate if sarcopenia is correlated with increased morbidity and mortality, pancreatic cancer biomarker patients with gastric adenocarcinoma.

Methods: We studied retrospectively all patients having radical resection for gastric adenocarcinoma managed in the Plasturi detoxifiere edera Hospital of Bucharest pancreatic cancer biomarker December and May ImageJ software was used to measure the patients' body composition.

We identified the L3 landmark and extracted that corresponding single cross-sectional image contained within a CT study.

Results: We reviewed 89 patients who had gastrectomy for cancer, but 11 Computed Tomography images were not available for analysis. Therefore, the study group consisted of 78 patients of which 50 were The average age of patients diagnosed with gastric cancer was The primary tumor location was the middle third of the stomach in 45 patients Pancreatic cancer biomarker were 72 The average sarcopenia value for both males and females is The greatest number of patients had a skeletal muscle index between The second greatest is between The muscular skeletal index correlated pancreatic cancer biomarker the age of the patients.

pancreatic cancer biomarker

The overall complications rate and the surgical site infection rate correlated with the sarcopenia. Conclusions: Sarcopenia is highly prevalent in patients having surgery for gastric cancer in Romania and correlates with increased postoperative morbidity. Especially with the increased trend for neoadjuvant therapy, the multidisciplinary team should evaluate and address sarcopenia through the perioperative period.

virus papillomavirus hpv condyloma acuminata incubation